P2Y12 Inhibitors May Be the Better Option for Secondary Prevention in CAD MedPage Today, 30 Aug 2022 Meeting Coverage > ESC Meta-analysis challenges central role of aspirin, researcher says by Ed Susman, Contributing Writer…